Loading clinical trials...
Loading clinical trials...
Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation for Cancers of the Mouth, Oropharynx, Hypopharynx and Nasopharynx
Conditions
Interventions
EC-18
Placebo
Locations
20
United States
Veterans Affairs Long Beach Health Care System
Long Beach, California, United States
UCLA Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
Miami Cancer Institute
Miami, Florida, United States
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
NorthShore University HealthSystem
Evanston, Illinois, United States
Start Date
July 3, 2018
Primary Completion Date
May 14, 2021
Completion Date
May 14, 2021
Last Updated
July 27, 2023
NCT07476625
NCT07475195
NCT07229469
NCT05878405
NCT06622213
NCT06421038
Lead Sponsor
Enzychem Lifesciences Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions